Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A46147 | 20724529 | Am J Physiol Gastrointest Liver Physiol | Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. | 2010 | Details |
A46149 | 20717042 | J Clin Gastroenterol | The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature. | 2011 | Details |
A46150 | 20714438 | Int J Med Sci | Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis. | 2010 | Details |
A46151 | 20710138 | South Med J | Nonalcoholic steatohepatitis: a review of the literature and updates in management. | 2010 | Details |
A46160 | 20653078 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
A46161 | 20653077 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
A46163 | 20648554 | Hepatology | Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. | 2010 | Details |
A46167 | 20633523 | J Acupunct Meridian Stud | Effects of Teucrium polium on Insulin Resistance in Nonalcoholic Steatohepatitis. | 2010 | Details |
A46174 | 20581678 | Curr Opin Lipidol | Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance. | 2010 | Details |
A46177 | 20566726 | CMAJ | Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. | 2010 | Details |
A46179 | 20530735 | Am J Physiol Endocrinol Metab | FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. | 2010 | Details |
A46184 | 20490434 | Braz J Med Biol Res | Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. | 2010 | Details |
A46189 | 20458758 | World J Gastroenterol | Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. | 2010 | Details |
A46191 | 20454765 | ScientificWorldJournal | Resolution of adipose tissue inflammation. | 2010 | Details |
A46196 | 20423314 | Curr Med Chem | Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders. | 2010 | Details |
A46198 | 20415823 | Dermatol Ther | Psoriasis, the liver, and the gastrointestinal tract. | 2010 | Details |
A46202 | 20391295 | Semin Thromb Hemost | Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver. | 2010 | Details |
A46203 | 20385430 | J Hepatol | Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance? | 2010 | Details |
A46205 | 20375212 | J Clin Endocrinol Metab | Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. | 2010 | Details |
A46209 | 20371660 | J Clin Endocrinol Metab | Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. | 2010 | Details |
A46212 | 20347746 | J Am Coll Surg | Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. | 2010 | Details |
A46213 | 20335584 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
A46214 | 20304711 | Dig Liver Dis | Introduction to the Mini-Symposium on non-alcoholic fatty liver disease. | 2010 | Details |
A46216 | 20225248 | Hepatology | Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. | 2010 | Details |
A46218 | 20222092 | Hepatology | Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. | 2010 | Details |
A46219 | 20217240 | Mol Biol Rep | Oxidative stress induced by high-glucose diet in liver of C57BL/6J mice and its underlying mechanism. | 2010 | Details |
A46221 | 20211973 | Endocrinology | Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. | 2010 | Details |
A46223 | 20207831 | Endocrinology | A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring. | 2010 | Details |
A46224 | 20207207 | Dig Liver Dis | Prevention and treatment of nonalcoholic fatty liver disease. | 2010 | Details |
A46225 | 20197789 | Eur J Clin Nutr | Berry meals and risk factors associated with metabolic syndrome. | 2010 | Details |
A46226 | 30764047 | Expert Rev Endocrinol Metab | Hepatitis C and metabolic syndrome. | 2010 | Details |
A46227 | 20185740 | Diabetes Care | Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. | 2010 | Details |
A46230 | 20159747 | Orv Hetil | [Patomechanisms of hepatic steatosis]. | 2010 | Details |
A46235 | 20137582 | Chin Med J (Engl) | Sleep apnea hypopnea syndrome and liver injury. | 2010 | Details |
A46240 | 20103702 | Diabetes | C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. | 2010 | Details |
A46242 | 20080361 | Med Hypotheses | Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin. | 2010 | Details |
A46244 | 20060143 | Metabolism | Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. | 2010 | Details |
A46246 | 20047129 | Swiss Med Wkly | Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance. | 2009 | Details |
A46248 | 20034933 | J Biol Chem | A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. | 2009 | Details |
A46257 | 19958653 | Zhonghua Gan Zang Bing Za Zhi | [Relationship between carotid atherosclerosis and nonalcoholic fatty liver disease]. | 2009 | Details |
A46262 | 19945406 | Cell Metab | Prevention of steatosis by hepatic JNK1. | 2009 | Details |
A46267 | 19918973 | Hepatology | Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice. | 2010 | Details |
A46269 | 19913850 | Metabolism | The possible role of liver steatosis in defining metabolic syndrome in prepubertal children. | 2009 | Details |
A46274 | 19849765 | Intern Med J | Non-alcoholic fatty liver disease and microalbuminuria in non-diabetic patients: role of insulin resistance. | 2009 | Details |
A46276 | 19838201 | Nat Med | Foxo1 integrates insulin signaling with mitochondrial function in the liver. | 2009 | Details |
A46278 | 19822488 | Hepatobiliary Pancreat Dis Int | Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? | 2009 | Details |
A46283 | 19783528 | J Lipid Res | A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. | 2009 | Details |
A46284 | 19772998 | J Pediatr | Pediatric nonalcoholic fatty liver disease in 2009. | 2009 | Details |
A46304 | 19637289 | Hepatology | Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. | 2009 | Details |
A46306 | 19616615 | Free Radic Biol Med | SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. | 2009 | Details |
A46310 | 19585655 | Hepatology | Adipokines in liver diseases. | 2009 | Details |
A46312 | 19576817 | J Pediatr Adolesc Gynecol | The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome. | 2009 | Details |
A46316 | 19561788 | Hippokratia | The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease. | 2009 | Details |
A46321 | 19553925 | Obesity (Silver Spring) | Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate. | 2009 | Details |
A46325 | 19541924 | Am J Physiol Gastrointest Liver Physiol | Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. | 2009 | Details |
A46327 | 19539084 | Am J Cardiol | A comparison of the prevalence of the MS and its complications using three proposed definitions in Korean subjects. | 2009 | Details |
A46328 | 19506316 | ILAR J | Metabolic consequences of sleep-disordered breathing. | 2009 | Details |
A46329 | 19502655 | Ann Hepatol | Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis. | 2009 | Details |
A46332 | 19475679 | Hepatology | The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance? | 2009 | Details |
A46340 | 19444870 | Hepatology | Independent effects of physical activity in patients with nonalcoholic fatty liver disease. | 2009 | Details |
A46342 | 19440711 | Semin Immunopathol | The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease? | 2009 | Details |
A46343 | 19426389 | J Dig Dis | Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease. | 2009 | Details |
A46345 | 19403641 | Am J Clin Nutr | Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. | 2009 | Details |
A46354 | 19346774 | Nestle Nutr Workshop Ser Pediatr Program | Obesity, inflammation, and macrophages. | 2009 | Details |
A46358 | 19333209 | Med Sci Monit | Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease. | 2009 | Details |
A46362 | 19307976 | Eur J Gastroenterol Hepatol | Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease. | 2009 | Details |
A46363 | 19303970 | Metabolism | Association between leptin and transaminases: 1-year follow-up study in 180 overweight children. | 2009 | Details |
A46366 | 19284314 | Metab Syndr Relat Disord | Metabolic syndrome and cancer. | 2009 | Details |
A46369 | 19262374 | Curr Opin Endocrinol Diabetes Obes | Nonalcoholic fatty liver disease in type 2 diabetes mellitus. | 2009 | Details |
A46373 | 19232511 | Arch Biochem Biophys | Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. | 2009 | Details |
A46376 | 19207680 | J Gastroenterol Hepatol | Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. | 2009 | Details |
A46382 | 19155012 | Atherosclerosis | Iron, metabolic syndrome, nonalcoholic fatty liver disease and carotid atherosclerosis. | 2008 | Details |
A46383 | 19145879 | Eksp Klin Gastroenterol | [Nonalcoholic fatty liver disease and insulin resistance: clinical, biochemical, and morphological parallels]. | 2008 | Details |
A46385 | 19141031 | Liver Int | Diabetic hepatosclerosis: a 10-year autopsy series. | 2009 | Details |
A46386 | 19131468 | Diabetes Care | Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents. | 2009 | Details |
A46387 | 19120938 | Liver Int | Propensity for non-alcoholic fatty liver disease: more evidence for ethnic susceptibility. | 2009 | Details |
A46389 | 19111006 | Hepatology | c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: Multiple roles in multiple steps. | 2009 | Details |
A46390 | 19105205 | Hepatology | Ethnic differences in hepatic steatosis: an insulin resistance paradox? | 2009 | Details |
A46393 | 19086170 | Scand J Gastroenterol | Reduced hepatic expression of adipose tissue triglyceride lipase and CGI-58 may contribute to the development of non-alcoholic fatty liver disease in patients with insulin resistance. | 2008 | Details |
A46394 | 19072357 | Expert Rev Gastroenterol Hepatol | Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. | 2008 | Details |
A46395 | 19062531 | Genetika | [Adipokine genetics: unbalanced protein secretion by human adipose tissue as a cause of the metabolic syndrome]. | 2008 | Details |
A46396 | 19053049 | Hepatology | Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. | 2009 | Details |
A46398 | 19046821 | Med Hypotheses | Adipose tissue transplantation may be a potential treatment for diabetes, atherosclerosis and nonalcoholic steatohepatitis. | 2008 | Details |
A46407 | 19027012 | Gastroenterology | Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. | 2008 | Details |
A46408 | 19000676 | Gastroenterology | The natural history of nonalcoholic fatty liver disease: insights from children and mice. | 2008 | Details |
A46410 | 21180527 | Therap Adv Gastroenterol | Treatment options for nonalcoholic Fatty liver disease. | 2008 | Details |
A46411 | 18972440 | Hepatology | Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. | 2008 | Details |
A46412 | 18971485 | Endocr Rev | The metabolic syndrome. | 2008 | Details |
A46415 | 18830789 | Obes Surg | Retinol and alpha-tocopherol in morbid obesity and nonalcoholic fatty liver disease. | 2008 | Details |
A46416 | 18827582 | Curr Opin Clin Nutr Metab Care | Nonalcoholic fatty liver disease: the potential role of nutritional management. | 2008 | Details |
A46418 | 20209757 | Rev Med Chir Soc Med Nat Iasi | [Adipocitokines and nonalcoholic steatohepatitis]. | 2010 | Details |
A46420 | 18794597 | Eur J Gastroenterol Hepatol | Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. | 2008 | Details |
A46421 | 18792129 | Hepatology | Does the hormone of eternal youth protect against nonalcoholic steatohepatitis? | 2008 | Details |
A46423 | 18787467 | Eur J Gastroenterol Hepatol | Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis. | 2008 | Details |
A46425 | 18772330 | Am J Pathol | Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. | 2008 | Details |
A46432 | 18685459 | Curr Opin Clin Nutr Metab Care | Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease. | 2008 | Details |
A46439 | 18666225 | Hepatology | Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. | 2008 | Details |
A46440 | 18664869 | J Pediatr Gastroenterol Nutr | Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children. | 2008 | Details |
A46442 | 18627005 | Hepatology | Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. | 2008 | Details |
A46443 | 18626435 | Ann Hepatol | Clinical update on non-alcoholic fatty liver disease and steatohepatitis. | 2008 | Details |